Related Experiment Video
Updated: Sep 10, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.2K
A Deep Learning Approach to Alzheimer's Diagnosis Using EEG Data: Dual-Attention and Optuna-Optimized SVM
Funda Bulut Arikan1, Dilber Cetintas2, Aziz Aksoy3
1Department of Physiology, Faculty of Medicine, Kirikkale University, Kirikkale 71451, Turkey.
Biomedicines
|August 28, 2025
Summary
Alzheimer's disease (AD) detection is improved using electroencephalography (EEG) frequency bands. Delta and Beta bands, analyzed with MobileNetV2 and attention mechanisms, show significant promise for faster, more accurate AD diagnosis.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Machine Learning
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-β plaques and tau tangles.
- Early diagnosis and management of AD are crucial for improving patient quality and duration of life.
- Real-time processing of mobile electroencephalography (EEG) data presents challenges for rapid AD detection.
Purpose of the Study:
- To identify specific EEG frequency bands associated with Alzheimer's disease.
- To accelerate Alzheimer's disease detection methods using EEG data.
- To achieve accurate and computationally efficient classification of AD.
Main Methods:
- EEG recordings from 48 individuals (24 AD, 24 healthy controls) were analyzed.
- Data were segmented into Alpha, Beta, Delta, Gamma, and Theta frequency bands.
- MobileNetV2 architecture, Dual-Attention Mechanism, and Support Vector Machine (SVM) with Optuna hyperparameter optimization were employed.
Main Results:
- Delta and Beta frequency bands were identified as most significant for AD detection.
- Attention mechanisms improved MobileNetV2 model performance by 2%.
- SVM with optimized hyperparameters showed an approximate 3% performance increase; feature fusion enhanced detection in larger datasets.
Conclusions:
- Frequency band analysis and feature fusion show potential for enhancing accuracy and efficiency in EEG-based AD diagnosis.
- The study highlights the utility of specific frequency bands and advanced machine learning techniques.
- Results are promising but require caution regarding generalizability to broader populations.
Related Concept Videos
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666

